Characterization of Synthetic Tf2 as a NaV1.3 Selective Pharmacological Probe
Mathilde R. Israel(King's College London), Thomas Durek(The University of Queensland), Stefanie Bothe(RWTH Aachen University), Irina Vetter(Centre National de la Recherche Scientifique), Samuel D. Robinson(The University of Queensland), Jennifer R. Deuis(The University of Queensland), David J. Craik(The University of Queensland), Angelika Lampert(Universitätsklinikum Aachen), Thomas S. Dash(The University of Queensland)
Cited by 9
Related Papers
A small-molecule inhibitor of the NLRP3 inflammasome for the treatment of inflammatory diseases
|Nature Medicine|2015|2.8k
Methods Used to Evaluate Pain Behaviors in Rodents
|Frontiers in Molecular Neuroscience|2017|1.3k
Pathophysiology of Chemotherapy-Induced Peripheral Neuropathy
|Frontiers in Molecular Neuroscience|2017|654
Conus Venom Peptide Pharmacology
|Pharmacological Reviews|2012|422
ConoServer: updated content, knowledge, and discovery tools in the conopeptide database
|Nucleic Acids Research|2011|374